Amgen Raises $140B in Public

Amgen has successfully raised $140B in a Public at a $150B valuation led by Public.

Company Overview

Amgen is a Biotech company headquartered in 1 Amgen Center Drive, Thousand Oaks, CA 91320, founded in 1980 with 24000+ employees.

Biotechnology company

Fundraising Details

Amount Raised: $140B
Round Type: Public
Valuation: $150B
Date: 2024-01-01
Investors: Public

About Amgen

Biotechnology company The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: 1 Amgen Center Drive, Thousand Oaks, CA 91320
Founded: 1980
Team Size: 24000+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Amgen's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Amgen's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $150B valuation marks an important milestone for Amgen, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Amgen is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-01-01. For more information about Amgen, visit their headquarters at 1 Amgen Center Drive, Thousand Oaks, CA 91320.